Immunization against Leishmania major infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens

OBJECTIVE(S): To design a multivalent DNA vaccine encoding the most immunogenic regions of the Leishmania major antigens including TSA (Thiol-specific antioxidant protein), LmSTI1 (Leishmania major stress-inducible protein1), LACK (Leishmania homologue of receptors for activated C Kinase), and KMP11...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Iran J Basic Med Sci
Päätekijät: Salehi-Sangani, Ghodratollah, Mohebali, Mehdi, Jajarmi, Vahid, Khamesipour, Ali, Bandehpour, Mojgan, Mahmoudi, Mahmoud, Zahedi-Zavaram, Hadi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Mashhad University of Medical Sciences 2019
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043880/
https://ncbi.nlm.nih.gov/pubmed/32133069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/IJBMS.2019.14051
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia